Concepedia

Author

Antonio Guglietta

Ferrer Grupo (Spain)

Also Known As

A Guglietta, A. GUGLIETTA, A. Guglietta, ANTONIO GUGLIETTA, Antonio Guglietta, Beydoun, Said R., Guglietta, A., Guglietta, Antonio

88

Publications

3K

Citations

26

H-Index

56

Concepts

All Affiliations

Ferrer Grupo (Spain)National Institute of Environmental Health SciencesFondazione IRCCS Istituto Neurologico Carlo BestaArgenx (Belgium)Leiden University Medical Center
AG

About

Antonio Guglietta is an author at Ferrer Grupo (Spain) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

18

1.4K

2

Natural Sciences

6

6

484

3

Engineering

1

1

70

4

Public Health

1

1

38

5

Anesthesia

1

1

13

Antonio Guglietta

×

37

Publications

2.7K

Citations

24

H-Index

YearCitations

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu,

The Lancet Neurology

2021

587

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Peter Ulrichts, Antonio Guglietta, Torsten Dreier,

Journal of Clinical Investigation

2018

334

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

James F. Howard, Vera Bril, Ted M. Burns,

Neurology

2019

268

The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy

Joel B. Epstein, Meir Gorsky, Antonio Guglietta,

Cancer

2000

137

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 1. Thiazolone and Oxazolone Series

Yuntao Song, David T. Connor, Robert Doubleday,

Journal of Medicinal Chemistry

1999

130

BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.

Marija Veljača, Charles A. Lesch, R Pllana,

Journal of Pharmacology and Experimental Therapeutics

1995

119

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series

Yuntao Song, David T. Connor, Anthony D. Sercel,

Journal of Medicinal Chemistry

1999

119

Novel Multipotent Tacrine−Dihydropyridine Hybrids with Improved Acetylcholinesterase Inhibitory and Neuroprotective Activities as Potential Drugs for the Treatment of Alzheimer's Disease

José Marco‐Contelles, Rafael León, Cristóbal de los Rı́os,

Journal of Medicinal Chemistry

2006

113

Dermorphin Gene Sequence Peptide with High Affinity and Selectivity for δ-Opioid Receptors

L.H. Lazarus, W.E. Wilson, Roberto Castiglione,

Journal of Biological Chemistry

1989

88

Synthesis, pharmacology and molecular modeling of N-substituted 2-phenyl-indoles and benzimidazoles as potent GABAA agonists

José Luis Falcó, Maria Piqué, Miguel A. González,

European Journal of Medicinal Chemistry

2006

70

Page 1